The Journal of Immunology, Vol 143, Issue 2 526-532, Copyright © 1989 by American Association of Immunologists

ARTICLES

IgG3 is the major source of cryoglobulins in mice

M Abdelmoula, F Spertini, T Shibata, Y Gyotoku, S Luzuy, PH Lambert and S Izui
Department of Pathology, University of Geneva, Centre Medicale Universitaire, Switzerland.

A total of 20 of 23 IgG3 mAb derived from unmanipulated autoimmune MRL/MpJ-lpr/lpr mice was shown to generate cryoglobulins which were composed exclusively of IgG3. Although three IgG3 mAb failed to develop cryoglobulins, they were able to bind nonspecifically to any IgG3 molecules as efficiently as cryoprecipitable IgG did. The direct role of the gamma 3 constant region for the generation of cryoglobulins was demonstrated by the following findings: 1) the cryoglobulin activity was independent of the specificity of the IgG3 mAb, 2) no mAb other than those of the IgG3 subclass, including IgM rheumatoid factors (RF), generated cryoglobulins, and 3) the cryoglobulin activity was gained after the Ig class switch of mAb from IgM to IgG3. Analysis of Ig components in three different sources of cryoglobulins, either induced by the injection of bacterial LPS or by the infection with Plasmodium yoelii in BALB/c mice or developed spontaneously in MRL/MpJ-lpr/lpr mice, revealed the selective concentration of IgG3 in these cryoglobulins; greater than 99%, 73% and 58% of IgG recoverable from these three cryoglobulins, respectively, were IgG3. This further attests to the major role of IgG3 in the generation of cryoglobulins in mice. In addition, the enhanced formation and even induction of IgG3 cryoglobulins in the presence of IgM anti-IgG3 RF mAb, and the enrichment of IgM RF in LPS- or malaria-induced cryoglobulins indicated that IgM RF can be involved in the generation of cryoglobulins by interacting with noncryoprecipitable IgG3 as well as cryoprecipitable IgG3.

This article has been cited by other articles:

				T. R. Kozel, P. Thorkildson, S. Brandt, W. H. Welch, J. A. Lovchik, D. P. AuCoin, J. Vilai, and C. R. Lyons Protective and Immunochemical Activities of Monoclonal Antibodies Reactive with the Bacillus anthracis Polypeptide Capsule Infect. Immun., January 1, 2007; 75(1): 152 - 163. [Abstract] [Full Text] [PDF]

				Y. Kuroda, A. Kuroki, S. Kikuchi, T. Funase, M. Nakata, and S. Izui A Critical Role for Sialylation in Cryoglobulin Activity of Murine IgG3 Monoclonal Antibodies J. Immunol., July 15, 2005; 175(2): 1056 - 1061. [Abstract] [Full Text] [PDF]

				T. D. de Stahl, J. Dahlstrom, M. C. Carroll, and B. Heyman A Role for Complement in Feedback Enhancement of Antibody Responses by IgG3 J. Exp. Med., May 5, 2003; 197(9): 1183 - 1190. [Abstract] [Full Text] [PDF]

				E. M. Yoo, L. A. Wims, L. A. Chan, and S. L. Morrison Human IgG2 Can Form Covalent Dimers J. Immunol., March 15, 2003; 170(6): 3134 - 3138. [Abstract] [Full Text] [PDF]

				S. Kikuchi, Y. Pastore, L. Fossati-Jimack, A. Kuroki, H. Yoshida, T. Fulpius, K. Araki, S. Takahashi, R. Lemoine, L. Reininger, et al. A Transgenic Mouse Model of Autoimmune Glomerulonephritis and Necrotizing Arteritis Associated with Cryoglobulinemia J. Immunol., October 15, 2002; 169(8): 4644 - 4650. [Abstract] [Full Text] [PDF]

				A. Kuroki, Y. Kuroda, S. Kikuchi, F. Lajaunias, T. Fulpius, Y. Pastore, L. Fossati-Jimack, L. Reininger, T. Toda, M. Nakata, et al. Level of galactosylation determines cryoglobulin activity of murine IgG3 monoclonal rheumatoid factor Blood, April 15, 2002; 99(8): 2922 - 2928. [Abstract] [Full Text] [PDF]

				T. Mizuochi, Y. Pastore, K. Shikata, A. Kuroki, S. Kikuchi, T. Fulpius, M. Nakata, L. Fossati-Jimack, L. Reininger, M. Matsushita, et al. Role of galactosylation in the renal pathogenicity of murine immunoglobulin G3 monoclonal cryoglobulins Blood, June 1, 2001; 97(11): 3537 - 3543. [Abstract] [Full Text] [PDF]

				H. Sekine, C. M. Reilly, I. D. Molano, G. Garnier, A. Circolo, P. Ruiz, V. M. Holers, S. A. Boackle, and G. S. Gilkeson Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/lpr Mice J. Immunol., May 15, 2001; 166(10): 6444 - 6451. [Abstract] [Full Text] [PDF]

				J.-U. Rengers, G. Touchard, C. Decourt, S. Deret, H. Michel, and M. Cogne Heavy and light chain primary structures control IgG3 nephritogenicity in an experimental model for cryocrystalglobulinemia Blood, June 1, 2000; 95(11): 3467 - 3472. [Abstract] [Full Text] [PDF]

				M. Ramos-Casals, O. Trejo, M. Garcia-Carrasco, R. Cervera, and J. Font Mixed cryoglobulinemia: new concepts Lupus, February 1, 2000; 9(2): 83 - 91. [Abstract] [PDF]

				H. Watanabe, G. Garnier, A. Circolo, R. A. Wetsel, P. Ruiz, V. M. Holers, S. A. Boackle, H. R. Colten, and G. S. Gilkeson Modulation of Renal Disease in MRL/lpr Mice Genetically Deficient in the Alternative Complement Pathway Factor B J. Immunol., January 15, 2000; 164(2): 786 - 794. [Abstract] [Full Text] [PDF]

				A. L. Gavin, N. Barnes, H. M. Dijstelbloem, and P. M. Hogarth Cutting Edge: Identification of the Mouse IgG3 Receptor: Implications for Antibody Effector Function at the Interface Between Innate and Adaptive Immunity J. Immunol., January 1, 1998; 160(1): 20 - 23. [Abstract] [Full Text] [PDF]

				R. Misiani, P. Bellavita, D. Fenili, P. Cacoub, F. Lunel, L. Musset, P. Opolon, J.-C. Piette, C. Werner, H. I. Joller-Jemelka, et al. Hepatitis C Virus and Cryoglobulinemia N. Engl. J. Med., April 15, 1993; 328(15): 1121 - 1124. [Full Text]